Osang Healthcare Co.,Ltd (KOSDAQ:036220)
South Korea
· Delayed Price · Currency is KRW 15,110
-40 (-0.26%)
Feb 21, 2025, 3:30 PM KST
Osang Healthcare Co.,Ltd Revenue
Osang Healthcare Co.,Ltd had revenue of 20.43B KRW in the quarter ending September 30, 2024, with 1.95% growth. This brings the company's revenue in the last twelve months to 75.71B, down -80.43% year-over-year. In the year 2023, Osang Healthcare Co.,Ltd had annual revenue of 355.85B with 83.53% growth.
Revenue (ttm)
75.71B
Revenue Growth
-80.43%
P/S Ratio
2.54
Revenue / Employee
226.68M
Employees
334
Market Cap
207.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 355.85B | 161.95B | 83.53% |
| Dec 31, 2022 | 193.89B | 61.57B | 46.53% |
| Dec 31, 2021 | 132.33B | -125.64B | -48.70% |
| Dec 31, 2020 | 257.97B | 207.58B | 412.01% |
| Dec 31, 2015 | 50.38B | -4.70B | -8.53% |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,364.39B |
| Celltrion | 2,876.25B |
| Yuhan | 2,008.84B |
| SK Biopharmaceuticals | 511.33B |
| SK bioscience | 201.30B |
| Hanmi Pharm. | 1,495.50B |
| Peptron | 2.41B |
| Hanall Biopharma | 134.24B |